Published Date : Mar 02, 2016
The global market for cardiovascular monitoring and diagnostic devices market has seen significant growth in the past few years. Quite understandably, the globally rising number of people with cardiovascular diseases is the major drive of this market. Sedentary lifestyles and poor diet and exercising habits are considered to be the major factors leading to the rising number of patients with cardiovascular diseases, and of several other lifestyle-related and chronic diseases.
The rising prevalence of a number of chronic diseases in all parts of the globe is considered one of the major challenges before the world currently. The WHO states that cardiovascular diseases will be the leading cause of mortality across the globe by 2030. This shocking fact has urged several healthcare companies to offer healthcare monitoring and disease diagnostic solutions that are affordable and easily accessible to the general consumer at large. Healthcare giants such as Boston Scientific Corporation, Philips Healthcare, GE Healthcare, St. Jude Medical, Inc., Nihon Kohden Corporation, Welch Allyn, Inc., and Siemens Healthcare are increasingly focusing towards the development of simple solutions for the complex ailments related to human heart.
The market for cardiovascular monitoring and diagnostic devices is thus reaching a level of maturation as several new devices are being introduced in the market on a regular basis. Several new cardiovascular diagnostic and monitoring devices in the market also have features that can offer information about preventive measures to the users.
A recent study by the European Society of Cardiology demonstrates that with the entry of next-generation devices such as smartwatches and the technological advancements seen in the market in the past few years, heart rate monitoring technologies have become easily reachable to a vast consumer base.
These next-generation cardiovascular monitoring devices come with the ability to diagnose and identify conditions such as atrial fibrillation. With features such as activity tracking, portability, and connectivity, these devices are becoming the best possible alternatives to non-invasive devices for cardiovascular conditions.